MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) — Charleston, South Carolina

MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gastroesophageal Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charleston

Browse all research sites in South Carolina · View every site in Charleston

• Duplicate_Medical University of South Carolina /ID# 228067
• Ralph H. Johnson Department of Veterans Affairs Medical Center
• Duplicate_Medical University of South Carolina /ID# 221072
• Medical University of South Carolina (MUSC) - Hollings Cancer Center
• Medical University of South Carolina /ID# 265113
• Medical University of South Carolina Weight Management Center
• Medical University South Carolina Hospitals and Clinics
• Medical University of South Carolina Children Hospital - PIN
• Medical University of South Carolina Hematology-Oncology Division
• Addiction Sciences Division-Medical University of South Carolina
• Medical University of South Carolina Infectious Disease Clinic
• Medical University of South Carolina (MUSC) - College of Medicine (COM)

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122)?

MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) conducted?

MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) has 1 clinical trials on record, with 1 currently active. Their work covers Gastroesophageal Cancer.

Is MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) accredited by Crixeo Clinical Trials?

MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.